Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates

Psychopharmacology

Volumn 156, Issue 1, 2001, Pages 79-85

  Meschler, J P ^a   Howlett, A C ^a   Madras, B K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cannabinoid; Dopamine; MPTP; Parkinson's disease; Primates

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; HALOPERIDOL; LEVONANTRADOL; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRADYKINESIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MALE; MONKEY; MOTOR PERFORMANCE; NONHUMAN; PARKINSON DISEASE; PRIMATE; PRIORITY JOURNAL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANALGESICS, NON-NARCOTIC; ANIMALS; CANNABINOIDS; DOPAMINE AGENTS; MACACA FASCICULARIS; MALE; MOTOR ACTIVITY; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0034942985     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100728     Document Type: Article

References (38)

1. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists
2. 9-tetrahydrocannabinol
3. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions
4. 9-tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain
5. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum
6. Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities
7. 9-tetrahydrocannabinol-induced responses and apparent agonist activity
8. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in the movement of an animal model of Parkinson's disease
9. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A
10. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
11. Modulation of neurotransmission by cannabinoids in the basal ganglia
12. 9-tetrahydrocannabinol and CP 55,940 in rats and rhesus monkeys
13. 9-tetrahydrocannabinol and the extrapyramidal system
14. 1 dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys
15. 11C]-CFT and PET in a primate model of parkinsonism
16. Cannabinoid receptor localization in brain: Relationship to motor and reward systems
17. Evaluation of intramuscular levonantradol and placebo in acute postoperative pain
18. 1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease
19. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists
20. 1 dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates
21. Cannabinoid and dopamine interaction in rodent brain: Effects on locomotor activity
22. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata
23. Tetrahydrocannabinol potentiates reserpine-induced hypokinesia
24. 9-tetrahydrocannabinol: Possible involvement of nigrostriatal dopaminergic alterations
25. 1 cannabinoid receptor in primate brain
26. Effect of aspirin on haloperidol-induced cataleptic behavior in mice
27. 1 cannabinoid receptor activity
28. The ring test: A quantitative method for assessing the 'cataleptic' effect of cannabis in mice
29. 9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors
30. Immunohistochemical localization of the neural cannabinoid receptor in rat brain
31. Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: Implications for Parkinson's disease?
32. 9-tetrahydrocannabinol elicited ipsilateral circling behavior in rats with unilateral nigral lesion
33. Effects of intrastriatal cannabinoids on rotational behavior in rats: Interactions with the dopaminergic system
34. 9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture
35. 3 receptor antagonists on neuroleptic-induced catalepsy in mice
36. Cannabinoid and dopamine interactions in the primate brain: Behavioral and cellular correlates
37. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
38. Behavioral effects of levonantradol and nantradol in the rhesus monkey